Business, energy, technology, markets and global industry news from Business News Today

nuclear medicine

PharmaDeviceNews nuclear medicine
Representative image of radiopharmaceutical preparation and PET imaging, illustrating how the Sanyou Bio and Baiyunshan Xihe collaboration aims to combine AI-led antibody discovery with nuclear medicine development for precision oncology.
Medical Devices & Diagnostics

AI meets nuclear medicine as Sanyou Bio and Baiyunshan Xihe pursue cancer diagnostics

Explore how Sanyou Bio and Baiyunshan Xihe are combining AI discovery and nuclear medicine to advance precision oncology theranostics.

Read More
Representative image: A nuclear medicine clinician monitors intravenous radiopharmaceutical administration, reflecting Radnostix’s acquisition of Lucerno Dynamics assets and its expansion into real-time extravasation monitoring, dosimetry and radioligand therapy workflows.
Medical Devices & Diagnostics

Lucerno Dynamics asset deal gives Radnostix new route into nuclear medicine workflows

Discover how Radnostix’s Lucerno Dynamics deal could reshape radiopharmaceutical monitoring, dosimetry and theranostics delivery.

Read More
Representative image: A modern radioligand therapy manufacturing centre under construction in Texas, highlighting Novartis AG’s investment in U.S. oncology infrastructure and the growing race to scale precision cancer treatment supply chains.
Medical Devices & Diagnostics

Novartis bets on Texas as radioligand therapy moves closer to mainstream oncology

RLT demand is rising faster than supply chains can stretch. Novartis’ Texas buildout tests whether precision oncology can scale.

Read More
Pharma & Biotech

What TAG1’s Lead-212 supply deal with Dana-Farber reveals about the future of radiopharmaceutical oncology

TAG1 and Dana-Farber partner to expand Lead-212 access for targeted alpha therapies. Discover what this means for radiopharmaceutical oncology innovation.

Read More